← Leaderboards
Leonardo Ferreira
University Of Florida
$5,268,494
Attributed
$5,268,494
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $816.6K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,268,494 · 5
By mechanism
R01$3,913,036 · 1
R00$735,048 · 1
R21$430,000 · 1
K99$121,189 · 1
R03$69,221 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Carol C Gregorio$19,713,203
- Ashok Kumar$1,371,719
- Julie A Maupin-Furlow$4,855,735
- Mohan K. Raizada$21,242,274
Others in their field
Top investigators on “Functional Disorder”
- Randall J Bateman · Washington University$164,791,794
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- David Heimbrook · Leidos Biomedical Research, Inc.$127,725,513
- Ed Lein · Allen Institute$92,850,604
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- John M Lachin · George Washington University$85,958,868
Research focus
Functional DisorderMorbidity - Disease RateReactive Oxygen SpeciesFatigueMuscleAffectPreventHeart FailureImpairmentFiberRespiratory MusclesMediatingOxidationProteinsEventMolecularBiologyMortalityExperimental StudyLimb StructureProtein FunctionAnimalsIn VitroMuscle Function
Grant awards (18)
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure$499,106
R01 · FY2025 · HL · contact PI
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure$491,865
R01 · FY2024 · HL · contact PI
Systemic antioxidant treatment for cardiomyopathy, muscle weakness, and exercise intolerance in postmenopausal HFpEF$201,250
R21 · FY2024 · AG · contact PI
Redox basis of diaphragm mitochondrial dysfunction and atrophy in heart failure$123,503
R01 · FY2024 · HL · contact PI
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure$444,136
R01 · FY2023 · HL · contact PI
Systemic antioxidant treatment for cardiomyopathy, muscle weakness, and exercise intolerance in postmenopausal HFpEF$228,750
R21 · FY2023 · AG · contact PI
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure$39,030
R01 · FY2023 · HL · contact PI
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure$436,193
R01 · FY2022 · HL · contact PI
Reactive oxygen species and respiratory muscle dysfunction in heart failure$376,014
R01 · FY2020 · HL · contact PI
Reactive oxygen species and respiratory muscle dysfunction in heart failure$378,189
R01 · FY2019 · HL · contact PI
Reactive oxygen species and respiratory muscle dysfunction in heart failure$375,000
R01 · FY2018 · HL · contact PI
Reactive oxygen species and respiratory muscle dysfunction in heart failure$375,000
R01 · FY2017 · HL · contact PI
Reactive oxygen species and respiratory muscle dysfunction in heart failure$375,000
R01 · FY2016 · HL · contact PI
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure$237,048
R00 · FY2013 · HL · contact PI
Mechanisms of reduced regenerative potential in aging skeletal muscle$69,221
R03 · FY2013 · AG · contact PI
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure$249,000
R00 · FY2012 · HL · contact PI
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure$249,000
R00 · FY2011 · HL · contact PI
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure$121,189
K99 · FY2010 · HL · contact PI